33JPY
333.00 MJPY
52.03 BJPY
2.74 M
About PHARMARISE HOLDINGS CORPORATION
Sector
CEO
Toshimichi Ohno
Headquarters
Tokyo
Website
Employees (FY)
1.56 K
Founded
1984
ISIN
JP3802320006
FIGI
BBG000JJSP47
Pharmarise Holdings Corp. engages in the management of its group of dispensing pharmacies. It operates through the following segments: Dispensing Pharmacy, Sales, Storage and Management of Medical Documents, Medical Mall Management, and Other. The Dispensing Pharmacy segment manages dispensing pharmacies that provides prescription drugs to general patients. The Sales segment handles the operation of drug stores and convenience stores and offers over-the-counter drugs, sanitary materials, cosmetics, and daily miscellaneous goods. The Storage and Management of Medical Documents segment covers the storage and management of medical examination records of patients on behalf of medical institutions. The Medical Mall Management segment deals with businesses related to the medical mall operated by its subsidiary. The Others segment includes the dispatchment of personnel and system integration business. The company was founded on June 28, 1984 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2796 is 656 JPY — it has increased by 0.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange PHARMARISE HOLDINGS CORPORATION stocks are traded under the ticker 2796.
PHARMARISE HOLDINGS CORPORATION is going to release the next earnings report on Jul 11, 2024. Keep track of upcoming events with our Earnings Calendar.
2796 stock is 0.92% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is PHARMARISE HOLDINGS CORPORATION there?
Yes, you can track PHARMARISE HOLDINGS CORPORATION financials in yearly and quarterly reports right on TradingView.
2796 stock has fallen by 0.15% compared to the previous week, the month change is a 2.50% rise, over the last year PHARMARISE HOLDINGS CORPORATION has showed a 3.31% increase.
2796 net income for the last quarter is −97.00 M JPY, while the quarter before that showed 150.00 M JPY of net income which accounts for −164.67% change. Track more PHARMARISE HOLDINGS CORPORATION financial stats to get the full picture.
Today PHARMARISE HOLDINGS CORPORATION has the market capitalization of 7.33 B, it has decreased by 0.31% over the last week.
PHARMARISE HOLDINGS CORPORATION dividend yield was 2.29% in 2022, and payout ratio reached 39.52%. The year before the numbers were 1.92% and 29.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2796 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARISE HOLDINGS CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 1.56 K employees. See our rating of the largest employees — is PHARMARISE HOLDINGS CORPORATION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARISE HOLDINGS CORPORATION technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARISE HOLDINGS CORPORATION stock shows the neutral signal. See more of PHARMARISE HOLDINGS CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMARISE HOLDINGS CORPORATION EBITDA is 2.57 B JPY, and current EBITDA margin is 5.12%. See more stats in PHARMARISE HOLDINGS CORPORATION financial statements.